Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR® 2025-12-03 08:43
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health 2025-12-02 22:00
Nature Communications | Insilico Medicine Presents AI-empowered Dual-Action PROTAC Targeting PKMYT1 2025-12-02 22:00
Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization 2025-12-02 20:00
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy 2025-12-02 17:00
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership 2025-12-02 15:00
Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement 2025-12-02 14:42
Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool 2025-12-01 17:10
From AI to Sustainability: International Innovation Awards 2025 Showcases Breakthroughs Driving the Next Wave of Global Innovation 2025-12-01 12:35
Oxford Instruments launches Imaris 11: boosting research productivity with clear, workflow-driven image analysis 2025-12-01 09:00
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development 2025-11-30 18:15
HZICC:Unlocked potential: why global innovators choose Hangzhou 2025-11-28 21:19
BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough 2025-11-28 21:00
Angel Yeast's 8,500-Ton Specialty Yeast Facility and New Brewing Microbial Pilot Platform Come Online 2025-11-28 20:58
Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025 2025-11-28 18:33
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours 2025-11-28 13:00
The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma 2025-11-28 12:32
Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Join Forces to Expand the Global Biopharma Market 2025-11-27 22:00
IASO Bio Announces BLA Approval of Fucaso (Equecabtagene Autoleucel) by the Hong Kong Department of Health for the Treatment of Relapsed or Refractory Multiple Myeloma 2025-11-27 13:44
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation 2025-11-27 10:39